Effect of CXCL12/CXCR4 on increasing the metastatic potential of non-small cell lung cancer in vitro is inhibited through the downregulation of CXCR4 chemokine receptor expression

Oncology Letters

Volumn 7, Issue 4, 2014, Pages 941-947

  Xie, Songping ^a   Zeng, Wenhui ^a   Fan, Guohua ^a   Huang, Jie ^a   Kang, Ganjun ^a   Geng, Qing ^a   Cheng, Bangchang ^a   Wang, Wei ^a   Dong, Ping ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Chemokine; CXCL12; CXCR4; Non small cell lung cance; RNA interference

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; SHORT HAIRPIN RNA; STROMAL CELL DERIVED FACTOR 1;

ARTICLE; CELL GROWTH; CELL INVASION; CELL MIGRATION ASSAY; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; LYMPHOCYTE HOMING; METASTASIS; MTT ASSAY; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 84896712445     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2014.1837     Document Type: Article

References (25)

1. Arriagada R, Bergman B, Dunant A, Le Chevalier T, Pignon JP and Vansteenkiste J; International Adjuvant Lung Cancer Trial Collaborative Group: Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 350: 351-360, 2004.
2. Jemal A, Murray T, Ward E, et al: Cancer statistics. CA Cancer J Clin 55: 10-30, 2005.
3. Mehlen P and Puisieux A: Metastasis: a question of life or death. Nat Rev Cancer 6: 449-458, 2006.
4. Gangadhar T, Nandi S and Salgia R: The role of chemokine receptor CXCR4 in lung cancer. Cancer Biol Ther 9: 409-416, 2010.
5. Vindrieux D, Escobar P and Lazennec G: Emerging roles of chemokines in prostate cancer. Endocr Relat Cancer 16: 663-673, 2009.
6. Müller A, Homey B, Soto H, et al: Involvement of chemokine receptors in breast cancer metastasis. Nature 410: 50-56, 2001.
7. Clapham PR and Weiss RA: Immunodeficiency viruses. Spoilt for choice of co-receptors. Nature 388: 230-231, 1997.
8. Liang JJ, Zhu S, Bruggeman R, et al: High levels of expression of human stromal cell-derived factor-1 are associated with worse prognosis in patients with stage II pancreatic ductal adenocacinoma. Cancer Epidemiol Biomarkers Prev 19: 2598-2604, 2010.
9. Castellone MD, Guarino V, De Falco V, et al: Functional expression of the CXCR4 chemokine receptor is induced by RET/PTC oncogenes and is a common event in human papillary thyroid carcinomas. Oncogene 23: 5958-5967, 2004.
10. Torregrossa L, Giannini R, Borrelli N, et al: CXCR4 expression correlates with the degree of tumor infiltration and BRAF status in papillary thyroid carcinomas. Mod Pathol 25: 46-55, 2012.
11. Su L, Zhang J, Xu H, et al: Differential expression of CXCR4 is associated with the metastatic potential of human non-small cell lung cancer cells. Clin Cancer Res 11: 8273-8280, 2005.
12. Spano JP, Andre F, Morat L, et al: Chemokine receptor CXCR4 and early-stage non-small cell lung cancer: pattern of expression and correlation with outcome. Ann Oncol 15: 613-617, 2004.
13. Phillips RJ, Burdick MD, Lutz M, et al: The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases. Am J Respir Crit Care Med 167: 1676-1686, 2003.
14. Phillips RJ, Mestas J, Gharaee-Kermani M, et al: Epidermal growth factor and hypoxia-induced expression of CXC chemokine receptor 4 on non-small cell lung cancer cells is regulated by the phosphatidylinositol 3-kinase/PTEN/AKT/mammalian target of rapamycin signaling pathway and activation of hypoxia inducible factor-1alpha. J Biol Chem 280: 22473-22481, 2005.
15. Broxmeyer HE, Orschell CM, Clapp DW, et al: Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J Exp Med 201: 1307-1318, 2005.
16. Ok S, Kim SM, Kim C, et al: Emodin inhibits invasion and migration of prostate and lung cancer cells by downregulating the expression of chemokine receptor CXCR4. Immunopharmacol Immunotoxicol 34: 768-778, 2012.
17. Xie S, Zeng W, Zuo T, et al: Expression and significance of CXCR4 chemokine receptor in non small cell lung cancer. Chin J Gen Pract 10: 1335-1336, 2012.
18. Huang YC, Hsiao YC, Chen YJ, et al: Stromal cell-derived factor-1 enhances motility and integrin up-regulation through CXCR4, ERK and NF-kappaB-dependent pathway in human lung cancer cells. Biochem Pharmacol 74: 1702-1712, 2007.
19. Zheng H, Dai T, Zhou B, et al: SDF-1alpha/CXCR4 decreases endothelial progenitor cells apoptosis under serum deprivation by PI3K/Akt/eNOS pathway. Atherosclerosis 201: 36-42, 2008.
20. Abedini F, Ismail M, Hosseinkhani H, et al: Effects of CXCR4 siRNA/dextran-spermine nanoparticles on CXCR4 expression and serum LDH levels in a mouse model of colorectal cancer metastasis to the liver. Cancer Manag Res 3: 301-309, 2011.
21. Orimo A, Gupta PB, Sgroi DC, et al: Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121: 335-348, 2005.
22. Rubie C, Frick VO, Ghadjar P, et al: CXC receptor-4 mRNA silencing abrogates CXCL12-induced migration of colorectal cancer cells. J Transl Med 9: 22, 2011.
23. Lee W, Jiang Z, Liu J, Haverty PM, Guan Y, Stinson J, et al: The mutation spectrum revealed by paired genome sequences from a lung cancer patient. Nature 465: 473-477, 2010.
24. Wald O, Izhar U, Amir G, et al: Interaction between neoplastic cells and cancer-associated fibroblasts through the CXCL12/CXCR4 axis: role in non-small cell lung cancer tumor proliferation. J Thorac Cardiovasc Surg 141: 1503-1512, 2011.
25. Sun YX, Wang J, Shelburne CE, et al: Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo. J Cell Biochem 89: 462-473, 2003.